TNF-induced activation of pulmonary microvessel endothelial cells: A role for GSK3β

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 296, Issue 4, 2009, Pages

  Johnson, Arnold ^a,b  

^a STRATTON VA MEDICAL CENTER   (United States)

^b ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

Glycogen synthetase kinase; Permeability

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 5 METHOXY 1H INDOL 3 YL] 3 (1H INDOL 3 YL)MALEIMIDE; BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; LUCIFERASE; PROTEIN KINASE C ALPHA; PROTEIN KINASE C INHIBITOR; RNA; SERINE; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR; 2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; INDOLE DERIVATIVE; MALEIMIDE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; IMMUNOMODULATION; LUNG BLOOD VESSEL; MICROVASCULATURE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; RAT; REPORTER GENE; VASCULAR ENDOTHELIUM; WILD TYPE; ANIMAL; CATTLE; CELL NUCLEUS; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; GENETICS; HUMAN; LUNG; METABOLISM; PHOSPHORYLATION; PROTEIN TRANSPORT; VASCULARIZATION;

ANIMALS; BETA CATENIN; CATTLE; CELL NUCLEUS; ENDOTHELIAL CELLS; ENZYME ACTIVATION; GLYCOGEN SYNTHASE KINASE 3; HUMANS; INDOLES; LUNG; MALEIMIDES; MICROVESSELS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN KINASE C-ALPHA; PROTEIN TRANSPORT; RATS; SERINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 65549167496     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.90566.2008     Document Type: Article

References (32)

1. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. β-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 16: 3797-3804, 1997. (Pubitemid 27280995)
2. Beckers CML, Garcia-Vallejo JJ, van Hinsbergh VWM, van Nieuw Amerongen GP. Nuclear targeting of β-catenin and p120ctn during thrombin-induced endothelial barrier dysfunction. Cardiovasc Res 79: 679-688, 2008.
3. Bhat RV, Haeberlein SLB, Avila J. Glycogen synthase kinase 3β: a drug target for CNS therapies. J Neurochem 89: 1313-1317, 2004. (Pubitemid 38802652)
4. Chen RH, Ding WV, McCormick F. Wnt signaling to β-catenin involves two interactive components glycogen synthase kinase-3β inhibition and activation of protein kinase C. Cancer 275: 17894-17899, 2000. (Pubitemid 30430843)
5. Daugherty RL, Gottardi CJ. Phospho-regulation of β-catenin. Adhesion and signaling functions. Physiology 22: 303-309, 2007.
6. Del Vecchio PJ, Siflinger-Birnboim A, Belloni PN, Holleran LA, Lum H, Malik AB. Culture and characterization of pulmonary microvascular endothelial cells. In Vitro Cell Dev Biol 28A: 711-715, 1992. (Pubitemid 23054043)
7. Douglas IS, del Valle FD, Winn RA, Voelkel NF. β-catenin in the fibroproliferative response to acute lung injury. Am J Respir Cell Mol Biol 34: 274-285, 2006.
8. Du Q, Park KS, Guo Z, He P, Nagashima M, Shao L, Sahai R, Geller DA, Hussain SP. Regulation of human nitric oxide synthase 2 expression by Wnt-β-catenin signaling. Cancer Res 66: 7024 -7031, 2006.
9. Dugo L, Abdelrahman M, Murch O, Mazzon E, Cuzzocrea S, Thiemermann C. Glycogen synthase kinase-3β inhibitors protect against the organ injury and dysfunction caused by hemorrhage and resuscitation. Shock 25: 485-491, 2006.
10. Eto M, Kouroedov A, Cosentino F, Lüscher TF. Glycogen synthase kinase-3 mediates endothelial cell activation by tumor necrosis factor-α. Circulation 112: 1316-1322, 2005. (Pubitemid 41266727)
11. Fang D, Hawke D, Zheng Y, Xia Y, Meisenhelder J, Nika H, Mills GB, Kobayashi R, Hunter T, Lu Z. Phosphorylation of β-catenin by Akt promotes β-catenin transcriptional activity. J Biol Chem 282: 11221-11229, 2007. (Pubitemid 47100795)
12. Ferro T, Clements R, Neumann P, Gertzberg N, Johnson A. Protein kinase C mediates endothelial barrier dysfunction induced by TNF-α. Am J Physiol Lung Cell Mol Physiol 278: L1107-L1117, 2000. (Pubitemid 30439233)
13. Gertzberg N, Gurnani T, Neumann P, Forbes AK, Louis NJ, Johnson A. Tumor necrosis factor-α (TNF) causes barrier dysfunction mediated by tyrosine198 and tyrosine218 in β-actin. Am J Physiol Lung Cell Mol Physiol 293: L1219-L1229, 2007. (Pubitemid 350159406)
14. Gonzalez P, Caballero M, Liton PB, Stamer WD, Epstein DL. Expression analysis of the matrix GLA protein and VE-cadherin gene promoters in the outflow pathway. Invest Ophthamol Vis Sci 45: 1389-1395, 2004. (Pubitemid 38859316)
15. Goodwin AM, Sullivan KM, D'Amore PA. Cultured endothelial cells display endogenous activation of the canonical Wnt signaling pathway and express multiple ligands, receptors and secreted modulators of Wnt signaling. Dev Dyn 235: 3110-3120, 2006.
16. Guo M, Breslin JW, Wu MH, Gottardi CJ, Yuan SY. VE-cadherin and β-catenin binding dynamics during histamine-induced endothelial hyperpermeability. Am J Physiol Cell Physiol 294: C977-C984, 2008.
17. Hagen T, Daniel ED, Culbert AA, Reith AD. Expression and characterization of GSK-3β mutants and their effect on β-catenin phosphorylation in intact cells. J Biol Chem 277: 23330-23335, 2002.
18. Hofmann S, Grasberger H, Jung P, Bidlingmaier M, Vlotides J, Janssen OE, Landgraf R. Tumor necrosis factor-alpha induced vascular permeability is associated with a reduction of VE-cadherin expression. Eur J Med Res 7: 171-176, 2002.
19. Kim JW, Lee JE, Kim MJ, Cho EG, Cho SG, Choi EJ. Glycogen synthase kinase 3 is a natural activator of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1 (MEKK1). J Biol Chem 278: 13995-14001, 2003.
20. Lee YH, Suzuki YJ, Griffin AJ, Day RM. Hepatocyte growth factor regulates cyclooxygenase-2 expression via β-catenin, Akt, and p42/p44 MAPK in human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 294: L778-L786, 2008.
21. Liu F, Schaphorst KL, Verin AD, Jacobs K, Birukova A, Day RM, Bogatcheva N, Bottaro DP, Garcia JG. Hepatocyte growth factor enhances endothelial cell barrier function and cortical cytoskeletal rearrangement: potential role of glycogen synthase kinase-3. FASEB J 16: 950-962, 2002. (Pubitemid 34753501)
22. Meijer L, Flajolet M, Greengard P. Pharmacological inhibitors of glycogen synthase kinase. Trends Pharmacol Sci 25: 471-480, 2004. (Pubitemid 39149703)
23. Neumann PH, Gertzberg N, Vaughan E, Weisbrot J, Woodburn R, Lambert W, Johnson A. Peroxynitrite mediates TNF-induced endothelial barrier dysfunction and nitration of actin. Am J Physiol Lung Cell Mol Physiol 290: L674-L684, 2006. (Pubitemid 43725072)
24. Ortega P, Moran A, deJuan C, Frias C, Hernandez S, Lopez-Asenjo JA, Sacnchez-Pernaute A, Torres A, Iniesta P, Benito M. Differential Wnt pathway gene expression and E-cadherin truncation in sporadic colorectal cancers with and without microsatellite instability. Clin Cancer Res 14: 995-1001, 2008.
25. Pongracz JE, Stockley RA. Wnt signaling in lung development and disease. Respir Res 7: 15-25, 2006.
26. Qatsha KA, Rudolpht C, Marmot D, Schachtelet C, May WS. Go6976, a selective inhibitor of protein kinase C, is a potent antagonist of human immunodeficiency virus 1 induction from latent/low-level-producing reservoir cells in vitro. Proc Natl Acad Sci USA 90: 4674-4678, 1993.
27. Siflinger-Birnboim A, Johnson A. Protein kinase C modulates pulmonary endothelial permeability: a paradigm for acute lung injury. Am J Physiol Lung Cell Mol Physiol 284: L435-L451, 2003. (Pubitemid 36231721)
28. Stambolic V, Woodgett JR. Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation. Biochem J 303:701-704, 1994. (Pubitemid 24325998)
29. Steel RGD, Torrie JH. Principles and Procedures of Statistics: a Biomedical Approach (2nd ed.). New York: McGraw-Hill, 1980, p. 173-177.
30. Vestweber D. VE-cadherin the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol 28: 223-232, 2008.
31. Viemann D, Goebeler M, Schmid S, Nordhues U, Klimmek K, Sorg C, Roth J. TNF induces distinct gene expression programs in microvascular and macrovascular human endothelial cells. J Leukoc Biol 80: 174-185, 2006.
32. Vines A, Cahoon S, Goldberg I, Saxena U, Pillarisetti S. Novel anti-inflammatory role for glycogen synthase kinase-3 in the inhibition of tumor necrosis factor-α and interleukin-1 induced inflammatory gene expression. J Biol Chem 281: 16985-16990, 2006. (Pubitemid 43909502)